Optimizing Bronchopulmonary Cancer Screening
Recruiting
N/A
Interventional Study
Bronchopulmonary Disease
Diagnoses Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 – 74
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 500 (estimated)
- Sponsor
- Institut Curie · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to evaluate the feasibility of performing a first screening for bronchopulmonary cancer by thoracic scanner in a French cohort within a dedicated, effective and structured network in the pilot centers participating in the study.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participant aged 50 to 74.
* Resident in the Île-de-France region.
* Active smoker or quit smoker for 10 years or less:
1. more than 10 cigarettes a day for more than 30 years,
2. more than 15 cigarettes a day for more than 25 years.
* The participant has been informed an…
Contacts